Mutations in the integrin α7 gene cause congenital myopathy


The basal lamina of muscle fibers plays a crucial role in the development and function of skeletal muscle. An important laminin receptor in muscle is integrin α7β1D. Integrin β1 is expressed throughout the body, while integrin α7 is more muscle-specific1–5. To address the role of integrin α7 in human muscle disease, we determined α7 protein expression in muscle biopsies from 117 patients with unclassified congenital myopathy and congenital muscular dystrophy by immunocytochemistry. We found three unrelated patients with integrin α7 deficiency and normal laminin α2 chain expression. To determine if any of these three patients had mutations of the integrin α7 gene, ITGA7, we cloned and sequenced the full-length human ITGA7 cDNA, and screened the patients for mutations. One patient had splice mutations on both alleles; one causing a 21 -bp insertion in the conserved cysteine-rich region, and the other causing a 98-bp deletion. A second patient was a compound heterozygote for the same 98-bp deletion, and had a 1-bp frame-shift deletion on the other allele. A third showed marked deficiency of ITGA7 mRNA. Clinically, these patients showed congenital myopathy with delayed motor milestones. Our results demonstrate that mutations in ITGA7 are involved in a form of congenital myopathy.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    von der Mark, H. et al. Skeletal myoblasts utilize a novel β1-series integrin and not α6β1 for binding to the E8 and T8 fragments of laminin. J. Biol. Chem. 266, 23593–23601 (1991).

  2. 2

    Song, W.K., Wang, W., Foster, R.F., Bielser, D.A. & Kaufman, S.J. H36-α7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J. Cell Biol. 117, 643–657 (1992).

  3. 3

    Collo, G., Starr, L. & Quaranta, V.A. . A new isoform of the laminin receptor integrin α7β1 is developmentally regulated in skeletal muscle. J. Biol. Chem. 268, 19019–19024 (1993).

  4. 4

    Song, W.K., Wang, W., Sato, H., Bielser, D.A. & Kaufman, S.J. Expression of α7 integrin cytoplasmic domains during skeletal muscle development: Alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases. J. Cell Sci. 106, 1139–1152 (1993).

  5. 5

    Ziober, B.L. et al. Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development. J. Biol. Chem. 268, 26773–26783 (1993).

  6. 6

    Hodges, B.L. et al. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J. Cell Sci. 110, 2873–2881 (1997).

  7. 7

    Vachon, P. et al. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 100, 1870–1881 (1997).

  8. 8

    Wang, W., Wu, W., Desai, T., Ward, D.C. & Kaufman, S.J. Localization of the alpha 7 integrin gene (ITGA7) on human chromosome 12q13: clustering of integrin and Hox genes implies parallel evolution of these gene families. Genomics 26, 568–570 (1995).

  9. 9

    Veiling, T. et al. Distinct alpha 7A beta 1 and alpha 7B beta 1 integrin expression patterns during mouse development: alpha 7A is restricted to skeletal muscle but alpha 7B is expressed in striated muscle, vasculature, and nervous system. Dev. Dyn. 207, 355–371 (1996).

  10. 10

    Kil, S. & Bronner-Fraser, M. Expression of the avian alpha 7-integrin in developing nervous system and myotome. Int. J. Dev. Neurosci. 14, 181–190 (1996).

  11. 11

    Fardeau, M. & Tomé, F.M.S. Congenital myopathies. in Myology. (eds Engel, A.G. & Franzini-Armstrong, C.) 1487–1532 (McGraw-Hill, Inc., New York, 1994).

  12. 12

    Dubowitz, V. Congenital muscular dystrophy, in Color Atlas of Muscle Disorders in Childhood, (ed. Dubowitz, V.) 52–65 (Year Book Medical Pub., Chicago, USA, 1989).

  13. 13

    Banker, B.Q. The congenital muscular dystrophies. in Myology (eds Engel, A.G. & Franzini-Armstrong, C.) 1275–1289 (McGraw-Hill, Inc., New York, USA, 1994).

  14. 14

    Mayer, U. et al. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nature Genet. 17, 318–323 (1997).

  15. 15

    Tomé, F.M.S. et al. Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. 317, 351–357 (1994).

  16. 16

    Philpot, J., Sewry, C., Pennock, J. & Dubowitz, V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc. Disord. 5, 301–305 (1995).

  17. 17

    Helbling-Leclerc, A. et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet. 11, 216–218 (1995).

  18. 18

    Guichehey, P. et al. Genetics of laminin alpha 2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis. Neuromusc. Disord. 7, 180–186 (1997).

  19. 19

    Kivirikko, S. et al. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum. Mol. Genet. 4, 959–962 (1995).

  20. 20

    Vidal, F. et al. Cloning of the laminin alpha 3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. Genomics 30, 273–280 (1995).

  21. 21

    Pulkkinen, L. et al. Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum. Mol. Genet. 6, 669–674 (1997).

  22. 22

    Ruzzi, L. et al. A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J. Clin. Invest. 99, 2826–2831 (1997).

  23. 23

    Georges-Labouesse, E. et al. Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nature Genet. 13, 370–373 (1996).

  24. 24

    Martin, P.T., Kaufman, S.J., Kramer, R.H. & Sanes, J.R. Synaptic integrins in developing, adult, and mutant muscle: selective association of α1, α7A, and α7B integrins with the neuromuscular junction. Dev. Biol. 174, 125–139 (1996).

  25. 25

    Hayashi, Y.K. et al. Abnormal localization of laminin subunits in muscular dystrophies. J. Neurol. Sci. 119, 53–64 (1993).

  26. 26

    Arahata, K. et al. Dystrophin diagnosis: comparison of dystrophin abnormalities by immunof luorescence and immunoblot analyses. Proc. Natl. Acad. Sci. USA 86, 7154–7158 (1989).

  27. 27

    Arahata, K. et al. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J. Neurol. Sci. 101, 148–156 (1991).

  28. 28

    Mizuo, Y., Yoshida, M., Nonaka, I. & Ozawa, E. Expression of utrophm (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve 17, 206–216 (1994).

  29. 29

    Yoshida, M., Mizuno, Y., & Ozawa, E. A dystrophin-associated glycoprotein, A3a (one of 43DAG doublets), is retained in Duchenne muscular dystrophy muscle. J. Biochem. 114, 634–639 (1993).

  30. 30

    Nagano, A. et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nature Genet. 12, 254–259 (1996).

Download references

Author information

Correspondence to Kiichi Arahata.

Rights and permissions

Reprints and Permissions

About this article

Further reading